Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia

Neurol Sci. 2016 Oct;37(10):1743-5. doi: 10.1007/s10072-016-2586-x. Epub 2016 Apr 20.

Authors

Chiara Di Pede¹, Stefano Masiero¹, Valentina Bonsangue¹, Rosario Marchese Ragona², Alessandra Del Felice³

Affiliations

¹ Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy.
² Department of Ear-Nose-Throat and Head-Neck Surgery, University of Padova, Padua, Italy.
³ Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy. alessandra.delfelice@unipd.it.

PMID: 27098244
DOI: 10.1007/s10072-016-2586-x

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Botulinum Toxins, Type A / therapeutic use*
Deglutition / physiology
Deglutition Disorders* / drug therapy
Deglutition Disorders* / ethnology
Deglutition Disorders* / rehabilitation
Female
Follow-Up Studies
Humans
Male
Myositis, Inclusion Body / complications*
Neuromuscular Agents / therapeutic use*

Substances

Neuromuscular Agents
Botulinum Toxins, Type A